Malaria Vaccine Pilot Demonstrations ‘Important First Step’ To Determining Role As Preventive Tool
The Lancet: What next for the malaria RTS,S vaccine candidate?
“On October 23, the Strategic Advisory Group of Experts on Immunization (SAGE) and the Malaria Policy Advisory Committee (MPAC) announced their much-anticipated recommendations for the world’s first malaria vaccine candidate known as RTS,S/AS01. Their decision is not to recommend widespread deployment of the vaccine based on existing evidence, but instead to assess the feasibility of delivering the vaccine and its impact in real-world settings. … The final policy recommendation on the vaccine from WHO is expected by the end of 2015. It has always been stressed that the vaccine could complement — not replace — existing proven malaria interventions. That might still be the case. But it is essential to show efficacy and feasibility outside a trial setting. SAGE and MPAC’s recommendation is an important first step to determine the vaccine’s future” (10/31).